Literature DB >> 16444763

Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress.

Peter Rösen1, Nicolas F Wiernsperger.   

Abstract

BACKGROUND AND AIM: This study was undertaken to test the hypothesis that hyperglycaemia induces the generation of reactive oxygen species (ROS) by mitochondria and that the oxidative stress thereby exerted is diminished by treatment with metformin. As a parameter of mitochondrial ROS formation, the activity of mitochondrial aconitase activity was determined using Goto-Kakizaki (GK) rats as model of type 2 diabetes.
METHODS: In parallel with the development of diabetes (glucose, insulin), the generation of oxidative stress was determined in aortic tissue, heart and kidney of GK rats by measurement of lipid peroxides, oxidized proteins (carbonyl activity) and mitochondrial aconitase activity. Vascular activity was determined in aortae by measuring the endothelium-dependent vasodilatation in response to acetylcholine, and vasoconstriction in response to phenylephrine.
RESULTS: At the age of 12-14 weeks, blood glucose levels rose dramatically from 7.5 up to 16.2 mM, indicating the manifestation of an overt diabetes. In addition, the glucose tolerance was impaired. The increase in blood glucose was not accompanied by changes in plasma insulin. Whereas the lipid peroxides in plasma only showed a tendency to increase, the amount of oxidized proteins (carbonyl moieties) increased from 4.6 to 10.9 micromol/mg protein (2.4 fold). In addition, the lipid peroxides in tissue were increased. Mitochondrial aconitase activity was reduced in the aorta and kidney, but not in the heart of diabetic animals. Treatment with metformin nearly normalized the hyperglycaemia and prevented the rise in carbonyl, tissue lipid peroxides and the fall in aconitase activity. Whereas the endothelium-dependent vasodilatation was not affected by the diabetes, the reaction of aortae in response to phenylephrine was strongly enhanced, changes which were prevented by treatment with metformin.
CONCLUSIONS: These observations provide in vivo evidence that the generation of ROS plays an important role in the onset of diabetes and the development of vascular dysfunction in GK rats with type 2 diabetes. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16444763     DOI: 10.1002/dmrr.623

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  39 in total

1.  Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.

Authors:  Jefferson C Frisbee; Matthew T Lewis; Jonathan D Kasper; Paul D Chantler; Robert W Wiseman
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

Review 2.  Diabetes and Kidney Disease: Role of Oxidative Stress.

Authors:  Jay C Jha; Claudine Banal; Bryna S M Chow; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

3.  Metformin Alleviated the Neuronal Oxidative Stress in Hippocampus of Rats under Single Prolonged Stress.

Authors:  Jiangang Wang; Bing Xiao; Fang Han; Yuxiu Shi
Journal:  J Mol Neurosci       Date:  2017-07-27       Impact factor: 3.444

4.  Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus.

Authors:  Hsien-Chang Lin; Joshua D Stein; Bin Nan; David Childers; Paula Anne Newman-Casey; Debra A Thompson; Julia E Richards
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

5.  Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus.

Authors:  Jan Skrha; Martin Prázný; Jirina Hilgertová; Jan Kvasnicka; Marta Kalousová; Tomás Zima
Journal:  Eur J Clin Pharmacol       Date:  2007-09-15       Impact factor: 2.953

6.  Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of nonobese NIDDM.

Authors:  Sachin Gupte; Nazar Labinskyy; Rakhee Gupte; Anna Csiszar; Zoltan Ungvari; John G Edwards
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

7.  Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control.

Authors:  Adriana M Hung; Christianne L Roumie; Robert A Greevy; Xulei Liu; Carlos G Grijalva; Harvey J Murff; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-06       Impact factor: 2.890

8.  Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH.

Authors:  Sabrina Serpillon; Beverly C Floyd; Rakhee S Gupte; Shimran George; Mark Kozicky; Venessa Neito; Fabio Recchia; William Stanley; Michael S Wolin; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

9.  Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction.

Authors:  Philip Wenzel; Swenja Schuhmacher; Joachim Kienhöfer; Johanna Müller; Marcus Hortmann; Matthias Oelze; Eberhard Schulz; Nicolai Treiber; Toshihiro Kawamoto; Karin Scharffetter-Kochanek; Thomas Münzel; Alexander Bürkle; Markus Michael Bachschmid; Andreas Daiber
Journal:  Cardiovasc Res       Date:  2008-07-02       Impact factor: 10.787

Review 10.  Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.

Authors:  William I Sivitz; Mark A Yorek
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.